Axoft
Axoft is a Next-Gen Electrodes & Materials company founded in 2022 and based in Cambridge, United States. It has raised $63M in total funding, most recently a Series A in 2026.
Develops soft, flexible neural electrode arrays designed to minimize scarring and improve long-term biocompatibility in brain implants. Raised $4.5M seed in 2023. Early-stage but backed by strong academic pedigree and IP from Xuanhe Zhao's lab at MIT.
Spun out of MIT with a platform that addresses one of the biggest failure modes in chronic implants—foreign-body response—using stretchable polymer technology.
axoft.co ↗·Next-Gen Electrodes & Materials·
United States·private 
